Harish Potu

545 total citations
17 papers, 439 citations indexed

About

Harish Potu is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Harish Potu has authored 17 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Hematology. Recurrent topics in Harish Potu's work include Ubiquitin and proteasome pathways (13 papers), Cell death mechanisms and regulation (6 papers) and Protein Degradation and Inhibitors (6 papers). Harish Potu is often cited by papers focused on Ubiquitin and proteasome pathways (13 papers), Cell death mechanisms and regulation (6 papers) and Protein Degradation and Inhibitors (6 papers). Harish Potu collaborates with scholars based in United States, Italy and India. Harish Potu's co-authors include Claudio Brancolini, Andrea Sgorbissa, Luke F. Peterson, Moshe Talpaz, Nicholas J. Donato, Malathi Kandarpa, Anupama Pal, Hanshi Sun, Ivana Manini and Monique Verhaegen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Harish Potu

17 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harish Potu United States	10	364	201	81	69	56	17	439
Prashant Sharma United States	11	424 1.2×	162 0.8×	68 0.8×	46 0.7×	55 1.0×	21	535
Swarna Mehrotra United States	7	269 0.7×	147 0.7×	115 1.4×	60 0.9×	66 1.2×	7	409
Chiel Maas Netherlands	13	342 0.9×	104 0.5×	91 1.1×	51 0.7×	66 1.2×	14	444
Sigrid Reichardt Germany	6	400 1.1×	217 1.1×	128 1.6×	40 0.6×	100 1.8×	6	533
Andrea Rabellino United States	10	480 1.3×	190 0.9×	100 1.2×	34 0.5×	83 1.5×	15	585
Phillip H. Koeffler United States	6	336 0.9×	205 1.0×	50 0.6×	58 0.8×	56 1.0×	13	467
Alice Callard United Kingdom	4	332 0.9×	122 0.6×	56 0.7×	54 0.8×	26 0.5×	5	414
Sebastian Łukasiak United Kingdom	8	397 1.1×	111 0.6×	117 1.4×	89 1.3×	77 1.4×	9	522
Janice M. Mehnert United States	8	303 0.8×	183 0.9×	52 0.6×	26 0.4×	58 1.0×	24	409
Harasim Thomas Germany	7	755 2.1×	233 1.2×	46 0.6×	31 0.4×	84 1.5×	7	841

Countries citing papers authored by Harish Potu

Since Specialization

Citations

This map shows the geographic impact of Harish Potu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harish Potu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harish Potu more than expected).

Fields of papers citing papers by Harish Potu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harish Potu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harish Potu. The network helps show where Harish Potu may publish in the future.

Co-authorship network of co-authors of Harish Potu

This figure shows the co-authorship network connecting the top 25 collaborators of Harish Potu. A scholar is included among the top collaborators of Harish Potu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harish Potu. Harish Potu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Potu, Harish, Malathi Kandarpa, Luke F. Peterson, et al.. (2021). Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanoma. Oncotarget. 12(3). 160–172. 11 indexed citations

Kandarpa, Malathi, Luke F. Peterson, Harish Potu, et al.. (2020). AML-397: Preclinical Efficacy of a PROTAC-based MDM2 Degrader in AML models. Clinical Lymphoma Myeloma & Leukemia. 20. S212–S212. 3 indexed citations

Potu, Harish, Malathi Kandarpa, Luke F. Peterson, Nicholas J. Donato, & Moshe Talpaz. (2019). Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells. Oncotarget. 10(56). 5745–5754. 9 indexed citations

Kandarpa, Malathi, Luke F. Peterson, Harish Potu, et al.. (2019). Improved Anti-Leukemic Pre-Clinical Efficacy of a Protac Based MDM2 Degrader in a Large AML Cohort. Blood. 134(Supplement_1). 2670–2670. 2 indexed citations

Kandarpa, Malathi, Luke F. Peterson, Harish Potu, et al.. (2019). Superior Pre-Clinical Efficacy of Novel Protac Based BET Degrader in a Large Acute Myeloid Leukemia Cohort. Blood. 134(Supplement_1). 3936–3936. 2 indexed citations

Pal, Anupama, Michele Dziubinski, Marina Pasca di Magliano, et al.. (2017). Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth. Neoplasia. 20(2). 152–164. 26 indexed citations

Potu, Harish, Luke F. Peterson, Malathi Kandarpa, et al.. (2017). Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma. Nature Communications. 8(1). 14449–14449. 53 indexed citations

Peterson, Luke F., Hanshi Sun, Yi‐Hong Liu, et al.. (2015). Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies. Blood. 125(23). 3588–3597. 101 indexed citations

Pal, Anupama, Marina Pasca di Magliano, Diane M. Simeone, et al.. (2015). Abstract 1748: Usp9x as a novel therapeutic target in human pancreatic cancer. Cancer Research. 75(15_Supplement). 1748–1748. 1 indexed citations

10.

Potu, Harish, Anupama Pal, Hanshi Sun, et al.. (2014). Abstract 4435: Deubiquitinases Usp9x and Usp5 control tumorigenicity and apoptotic responsiveness in malignant melanoma. Cancer Research. 74(19_Supplement). 4435–4435. 2 indexed citations

11.

Potu, Harish, Luke F. Peterson, Anupama Pal, et al.. (2014). Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway. Oncotarget. 5(14). 5559–5569. 57 indexed citations

12.

Manini, Ivana, et al.. (2013). The DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels. Cancer Biology & Therapy. 14(12). 1158–1166. 16 indexed citations

13.

Sgorbissa, Andrea, et al.. (2011). Type I IFNs signaling and apoptosis resistance in glioblastoma cells. APOPTOSIS. 16(12). 1229–1244. 35 indexed citations

14.

Potu, Harish, Andrea Sgorbissa, & Claudio Brancolini. (2010). Identification of USP18 as an Important Regulator of the Susceptibility to IFN-α and Drug-Induced Apoptosis. Cancer Research. 70(2). 655–665. 78 indexed citations

15.

Sgorbissa, Andrea, Harish Potu, & Claudio Brancolini. (2010). Isopeptidases in anticancer therapy: looking for inhibitors.. PubMed. 2(3). 235–47. 9 indexed citations

16.

Potu, Harish, Enrico Crivellato, Roberta Maestro, et al.. (2009). The Isopeptidase Inhibitor G5 Triggers a Caspase-independent Necrotic Death in Cells Resistant to Apoptosis. Journal of Biological Chemistry. 284(13). 8369–8381. 30 indexed citations

17.

Madasu, Yadaiah, et al.. (2007). Cloning, E. coli expression, refolding, and ATP-binding properties of a WD40-deleted Apaf-1 isoform. Protein Expression and Purification. 56(2). 220–228. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact